Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases

American Journal of Pathology

Volumn 156, Issue 2, 2000, Pages 585-594

  Takano, Yasuo ^a,b   Kato, Yo ^b   Van Diest, Paul J ^c   Masuda, Mitsunobu ^d   Mitomi, H ^a   Okayasu, I ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d Yokohama City University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN E; MESSENGER RNA; PROTEIN P27;

ARTICLE; CANCER SURVIVAL; CELL CYCLE; DIGESTIVE SYSTEM CANCER; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; STOMACH CANCER;

EID: 0033874069     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64763-3     Document Type: Article

References (58)

1. The D-type cyclins and their role in tumorigenesis
2. Mammalian G1 cyclins
3. Translational control of p27 accumulation during the cell cycle
4. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
5. Redundant cyclin overexpression and gene amplification in breast cancer cells
6. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
7. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma
8. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
9. Cyclin D1 overexpression in malignant lymphomas
10. Amplification of cyclin genes in colorectal carcinomas
11. Cancer cell cycle
12. EDNA-2 and EBNA-LP cooperate to cause G0 to G1 Transition during immortalization of resting human B-lymphocytes by Epstein-Barr virus
13. Cyclin D1 in invasive breast cancer: Correlations, and prognostic value
14. Expression of cyclin D1 and E in human colon adenocarcinomas
15. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E
16. Frequent amplification of the cyclin E gene in human gastric carcinoma
17. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas
18. Differential expression and regulation of cyclin D1 protein in normal and tumor cells: Association with cdk4 is required for cyclin D1 function in G1 progression
19. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas
20. Role of p27(Kip1) and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer
21. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-ß
22. p27(kip1) A cyclin-cok inhibitor, links transforming growth factor-ß and contact inhibition to cell cycle arrest
23. Interleukin-2-mediated elimination of p27(Kip1) cyclin-dependent kinase inhibitor prevented by rapamycin
24. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
25. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
26. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
27. Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer
28. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
29. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
30. Reduced expression of cyclin-dependent kinase inhibitor p27(Kip1) is associated with advanced stage and invasiveness of gastric carcinomas
31. p27 Expression and gastric carcinoma
32. Prostate stem cell compartments: Expression of the cell cycle inhibitor p27(Kip1) in normal, hyperplastic, and neoplastic cells
33. Loss of cyclin-dependent kinase inhibitor p27(Kip1) is a novel prognostic factor in localized human prostate adenocarcinoma
34. Cyclin-dependent kinase inhibitor p27(kip1) in lymphoic tissue: p27(kip1) Expression is inversely proportional to the proliferative index
35. Pathological studies of human gastric cancer
36. Cyclin D1 and prognosis in human breast cancer
37. Cyclin D2 but not cyclin D1 overexpression closely correlates with gastric cancer progression and prognosis
38. Low p27 expression predicts poor disease-free survival in patients with prostatic cancer
39. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
40. Cyclin D1 protein is overexpressed in hyperplasia, and intraductal carcinoma of the breast
41. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma
42. Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer
43. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types
44. Subunit rearrangement of the cyclin-dependent kinase is associated with cellular transformation
45. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
46. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients
47. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells
48. Expression of cell cycle regulatory factors in differentiating osteoblasts: Postproliferative up-regulation of cyclin B and E
49. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-CDK2 and cyclin D1-CDK2 complexes
50. Expression of cell-cycle regulators p27(Kip1) and cyclin E, atone and in combination, correlate with survival in young breast cancer patients
51. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein
52. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas
53. Human cyclin D1 oncogene and esophageal squamous cell carcinoma
54. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer
55. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification
56. Cyclin D1 and retino blastoma gene expression in human breast carcinoma: Correlation with turnout proliferation and oestrogen receptor status
57. Anchorage-dependent transcription of the cyclin A gene
58. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases